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ABSTRACT
Cerebrovascular diseases are a global medical and social issue because of the high morbidity, mortality and 
disability they cause. WHO announces 15 Mio ischemic stroke occurrences per year globally, with 5 Mio as-
sociated deaths and 5 Mio left permanently disabled. Thrombolysis (TL) with tissue plasminogen activator 
(rt-PA) is currently an approved differentiated pharmaco-therapeutic treatment of ischemic stroke (IS) in 
its acute phase. There is irrefutable evidence of better health results and efficient clinical management of 
ischemic strokes within an integrated therapeutic approach as a key factor for improving the functional out-
come in stroke patients. Quality is one of the most widely discussed issues in the theory and practice of dis-
ease management. The rigid compliance with the standards for treatment of ischemic strokes is an indica-
tor of high quality patient management.
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INTRODUCTION
Ischemic stroke (IS) is the fourth leading cause 
of death in the USA and the second in Australia af-
ter ischemic heart disease, with an approximate rate 
of 60 000 cases per year. Mortality is higher in Cen-
tral and Eastern Europe as compared to Northern, 
Southern and Western Europe (1), and over the past 
2 years, the leaders in mortality from cerebrovas-
cular diseases are Bulgaria, Romania, Latvia and 
Macedonia. 
According to the National Health Information 
Center, in 2009 there were 50 678 cases of IS, of which 
95.8% (48 551) were hospitalized. The prevalent cas-
es are of acute ischemic stroke (AIS) – 85.6% (43 578 
case), with 51.2% of the incidents being women (2).
Thrombolysis (TL) with rt-PA is currently an 
approved differentiated pharmaco-therapeutic treat-
ment of ischemic stroke (IS) in its acute phase (3). 
A number of multicenter international research-
es confirm the therapeutic effect and safety of the Ac-
tilyse® medication as compared to placebo in AIS pa-
tients: NINDS (1995), ECASS I, II, III (1995, 1999, 
2003), ATLANTIS and the relatively low percentage 
of symptomatic intracranial hemorrhages (4). 
Based on the results from these researches, and 
as recommended by the AНA (American Heart As-
sociation), ASO (American Stroke Association) and 
ESO (European Stroke Association), in 2010 the time 
for implementing i.v. thrombolytic was increased 
from 3 to 4.5 hours (5).
In Bulgaria the first TL with rt-PA was done in 
2005 in the city of Plovdov (2). 
There is irrefutable evidence of better health re-
sults and efficient clinical management of ischemic 
strokes within an integrated therapeutic approach as 
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a key factor for improving the functional outcome in 
stroke patients (6,7).
AIM
Quality is one of the most widely discussed is-
sues in the theory and practice of disease manage-
ment. The aim is to present different useful and sci-
entifically based activities for input of quality indi-
cators in diagnostics, treatment and rehabilitation of 
stroke patients. 
MATERIAL AND METHODS
The present study shows international research-
es in which the priority is to improve the quality in-
dicators, which must meet the requirements of the 
medical service users.
Quality Indicator is a measure unit for deter-
mining the level of adherence to standards in health-
care and an element in the medical aid system which 
helps to determine the level of the achieved result or 
the level of compliance to select rules and standards 
(8).
These indicators are used for monitoring the 
quality of medical and managerial activities within 
the healthcare system and represent and tool for data 
collection. There are three approaches for measuring 
and assessment of quality:
 ❖ The structural approach – analysis of input pa-
rameters (structure, staff qualification, profes-
sional teams);
 ❖ Process analysis – assessment of activities (pro-
motion, prevention, prophylaxis, diagnostics, 
therapy and rehabilitation);
 ❖ Outcome analysis – the effect of the activities 
leading to a change in the patient’s health status.
The measuring of quality is a complex of activi-
ties aimed at collecting information, which will con-
firm whether the goals of a particular program or ac-
tivity have been achieved. In order to measure the 
quality of medical care, it is necessary to develop and 
implement a panel of criteria on the quality of medi-
cal care (9,10). 
First, quality indicators must be adhered to for 
all patients, except under unforeseen circumstances. 
Second, quality indicators have to determine how to 
identify in practice those patients who require specif-
ic approaches. And third, quality indicators shall re-
late to a specific result, to be valid and reliable, to al-
low to be measured, to be variable, and the observed 
differences between the hospitals must come from 
the work at the hospital itself and not from the dif-
ferences in the characteristics of the patients. Also, 
quality indicators may change in the process of the 
change of the practices of caring for the patients.
The quality indicator must meet the following 
characteristics:
 ❖ Be measurable (Can it be counted, written 
down? – e.g. an hour?);
 ❖ Be achievable (Can it be achieved in practice?);
 ❖ Be interpretable (What does its existence 
mean?);
 ❖ Lead to a result (Can something be done about 
it?);
 ❖ Be timely (Does the indicator have a short-term 
and long-term significance?);
 ❖ Be engaging (Do the indicators cover the work 
of the whole team?);
 ❖ Be balanced (Do the indicators cover the full 
cycle of the process?).
Results are the most valuable final criterion for 
quality assessment, as they reflect the useful effect of 
healthcare services (e.g. decrease in disability, mortal-
ity etc. rates.).
In relation with the practical sphere, particular 
diagnostic-therapeutic indicators have been devel-
oped. Those indicators are grouped in relation to the 
different quality components.
RESULTS
The work team of the European Quality Im-
provement Programme (EQuiP) has developed and 
offered for implementation the following definition 
of a quality indicator: „such a measurable element 
of practice performance, based on scientific proof, for 
which there is evidence or consensus that it can be 
used to assess quality and hence change in quality of 
care provided.“ 
Therefore with the aid of the indicators, quality 
can be measured by establishing their presence or ab-
sence or by determining their values with each user. 
The monitoring system as a step on the way to 
guaranteeing quality is a system of periodical data 
collection and data analysis of selected indicators 
(11). 
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The Indicators are clearly formulated notices of 
expected quality. They can be determined for each 
component of the system, namely – structure, pro-
cess and outcome and can be defined either on the 
basis of a quality or a quantity principle (12,13).
In relation with the optimization of quality 
management in healthcare the EUPHORIC program 
has been implemented in the practice performance. 
EUPHORIC is a multidisciplinary project co-fi-
nanced by the EU for the period 2003-2008. 
The basic aim of the project is to integrate the 
already existing practical experience and knowledge 
in the participating countries: Austria, Bulgaria, Fin-
land, France, Germany, Greece, Israel, Italy, the Slo-
vak Republic, Spain and Sweden, in order to:
 ❖ Establish a possibility for developing common 
indicators for outcomes in the sphere of health-
care, valid across Europe;
 ❖ Assess quantity indictors for outcomes from se-
lect medical practices by developing standard-
ized methodology, based on extensive informa-
tion, on the outcome indicators and a research 
on the validity of the gathered information dur-
ing routine practice;
 ❖ Offer objective and transparent high quality in-
formation which is readily available to users;
 ❖ Exchange information about the quality of 
the standards, good practices and efficacy in 
healthcare.
The project’s main task is assessment of health-
care systems in view of improving therapy. 
The EUPHORIC project indicators referring to 
ischemic stroke are:
 ❖ Emergency stroke iatrogenic readmission in 
hospital;
 ❖ Death at the 30th day after admission with a 
stroke diagnosis;
 ❖ Death during hospitalization and neurological 
complications as a result of carotid artery stent 
placement;
 ❖ Death and neurological complications at 30 
days after carotid artery stent placement (14).
The so called benchmarking also plays an im-
portant role in the management of AIS. 
Benchmarking is a process of measuring the op-
erations of an organization as compared to similar 
operations of other organizations in view of improv-
ing process management. Another definition is: “a 
constant systematic process of assessment of products, 
services and works processes of organizations which 
represent the best practices, aiming at improvement of 
the whole organization“.
The benchmarking programme’s priority is the 
development of indicators in view of giving and assess-
ment and analysis of the practice. The development of 
this set of indicators stimulates the improvement of 
quality and will create a stimulus for constant per-
fecting [17, 18]. It is difficult to identify indicators of 
general validity for the healthcare sector for the fol-
lowing reasons:
 ❖ It is difficult to measure directly the achieved 
results in the healthcare sector;
 ❖ The results can fall simultaneously into differ-
ent spheres of reporting;
 ❖ The results are not by all means related to one 
only aspect of the provided care; they are rath-
er the result of a number of phases of testing, 
treatment and assessment.
In 2006, the European Implementation Score 
(EIS) was started, relating to accounting for the dif-
ferences in the quality indicators in the care and 
treatment of acute stroke patients in six European 
countries – Belgium, England, Germany, Sweden, 
Spain and Scotland. The results were published in 
Stroke journal in 2012 (15). 
Over 123 indicators have been identified in the 
scope of managing AIS (91 process related indicators; 
24 with results, 8 structural indicators) (15).
The anticoagulants in patients with rhythm-
conduction disturbance on the neuroimaging tests 
were the only quality indicators used all around (16). 
Thirteen quality indicators were used in at least two 
countries. The recorded substantial differences at 
the audit in the different centres and countries were 
only related to the process of developing the quality 
indicators. 
The conclusions from the research show that 
there is a great variety in the measuring of the ef-
ficiency in the care for stroke patients in Europe, 
which hinders the comparability of the indicators. 
Common indicators are needed for determining the 
quality indicators which have to be accepted and val-
idated in Europe (17).
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Figure 1 shows the quality indicators in the 
project participating countries. 
There are differences in the applied quality in-
dicators in the treatment of acute stroke on both re-
gional and national levels in the participating coun-
tries (figures 1, 2, 3, 4). 
DISCUSSION
According to WHO of 1987:  
“In health care establishments, quality is an ap-
proach which is called to guarantee each and every pa-
tient the aggregate of diagnostic and therapeutic ac-
tivities which will ensure the best possible outcome in 
view of health in accordance with the current state of 
the medical science, with the best assessment for same 
outcome, and the lowest possible iatrogenic risk and a 
deep satisfaction from the procedures, outcomes and 
human contact within the health care system”.
EU health policies are based on the best scien-
tific proof, grounded in verifiable, scientific data, in-
formation and the necessary tests. In the first, and 
later, in the second health programs, the EU adopted 
the integrated approach to health care – intersector 
cooperation and activities for rendering health in-
formation, a fast response to health threats and pro-
moting health through factors crucial for health. The 
membership of Bulgaria in the EU and the respon-
sibility of the state relating to this membership, the 
changing public relations and economic conditions 
in the country and the necessity for guaranteeing a 
high level of health care, require analysis and assess-
ment of the situation within the healthcare system, as 
well as updating of the guidelines on providing sus-
tainable development and efficiency (18).
Fig. 1. Quality indicators in the treatment of acute stroke 
on a national level in the participating counties (Frances-
ca Romana Pezzella, Stroke Unit, AO S Camillo-Forlani-
ni, Rome, Italy – ESO Conference, 2015 – Glasgow)
Fig. 2. Quality indicators in the treatment of acute stroke 
on a regional level in the participating countries (Frances-
ca Romana Pezzella, Stroke Unit, AO S Camillo-Forlani-
ni, Rome, Italy – ESO Conference, 2015 – Glasgow)
Fig. 3. Quality indicators in the treatment of acute stroke 
on a national level in the participating countries (Franc-
esca Romana Pezzella, Stroke Unit, AO S Camillo-Forla-
nini, Rome, Italy – ESO Conference, 2015 – Glasgow) 
Fig. 4. Quality indicators in the treatment of acute stroke 
on a regional level in the participating countries (Frances-
ca Romana Pezzella, Stroke Unit, AO S Camillo-Forlani-
ni, Rome, Italy – ESO Conference, 2015 – Glasgow) 
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AIS treatment has progressed greatly recently. 
A large number of innovative methods have been im-
plemented in an attempt to improve therapeutic prac-
tices. International research shows an ever increasing 
efficiency in the treatment of ischemic stroke at the 
specialised units for treatment of stroke as compared 
to conventional therapy practices; their prognostica-
tion use is deemed irrefutable. The organisation of 
medical care and mainly the succession of the differ-
ent stages of medical aid are very important – diag-
nostics and treatment in the acute stage, secondary 
prevention and early rehabilitation (19,20,21).
The implementation of multidisciplinary ap-
proaches in AIS patients leads to decreased mortal-
ity, disability and a better clinical outcome of the dis-
ease (22,23).
Of utmost importance for the increase of qual-
ity of service of stroke patients is the development of 
diagnostic-therapeutic algorithms (protocols) which 
give important information about all the key re-
sources necessary for the planning of hospital prac-
tice on all levels, and at the same time enhancing the 
cooperation between practice and theory while at the 
same time accounting for hospital practice quality.
Introducing disease severity levels as a basic mea-
surement principle. The defining of the medical pa-
rameters of disease severity is a prerequisite for using 
exact characteristics of the case-mix approach when 
classifying and measuring the hospital product. The 
introduction of therapeutic goals and outcome of the 
disease, relating to the severity will specify the data 
about the types of the treated patients (24). 
The defining and monitoring of standardized 
quality indicators aimed at different aspects of clini-
cal practice can be exceptionally useful in daily clini-
cal practices (25). Further research is needed in view 
of defining unified quality indicators in clinical prac-
tice as regards acute ischemic stroke patients.
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